Neal, Samuel R.Wood, Adrian D.Ablett, Andrew D.Gregory, Jenny S.Guillot, JordanMacdonald, Helen M.Reid, David M.Myint, Phyo Kyaw2020-06-162020-06-162020Neal, S R, Wood, A D, Ablett, A D, Gregory, J S, Guillot, J, Macdonald, H M, Reid, D M & Myint, P K 2020, 'Anticholinergic burden in middle-aged women and recurrent falls in later life : findings from the Aberdeen Prospective Osteoporosis Screening Study (APOSS)', Therapeutic Advances in Drug Safety, vol. 11, pp. 1-9. https://doi.org/10.1177/20420986209298522042-0986PubMedCentral: PMC7273562ORCID: /0000-0003-3852-6158/work/163198620https://hdl.handle.net/2164/14508ACKNOWLEDGEMENTS AND FUNDING The Aberdeen Prospective Osteoporosis Screening Study (APOSS) was funded by the Grampian Osteoporosis Trust. SRN received an Aberdeen Summer Research Scholarship supported by funding from the Institute of Applied Health Sciences, University of Aberdeen, UK. The funder had no role in design, analysis, interpretation or reporting of the work presented. We gratefully acknowledge the Steering Committee of APOSS for their permission to conduct this research.9193335engAccidental FallsCholinergic AntagonistsMiddle AgedPolypharmacyaccidental fallscholinergic antagonistsmiddle agedpolypharmacyR Medicine (General)Pharmacology (medical)R1Journal article10.1177/2042098620929852http://www.scopus.com/inward/record.url?scp=85085623757&partnerID=8YFLogxK11